What are the odds? Again, these facilities were owned by Cognate (that was previously owned by Linda Power’s Toucan), the CRL (Charles River Labs) and, as of late April 2026, now owned by GI Partners (subsidiary is CDMO Rose Biosolutions) and their FOUR facilities are in these non-random locations.
Primary Rose CDMO facility:
Memphis Tennessee, built to specifically make DCVax-l, larger capacity than Sawston and off site storage also larger than Sawston.
Other three:
Rockville, Maryland (8.1 Miles from NWBO headquarters)
Northridge, California (16 miles from UCLA)
Keele, GB (NWBO 2026 1st 10Q refers to
”another region of the UK, using an existing established GMP facility” which the Keele building fits to a T.)
And now, with regard to the U.S., LP is currently re-emphasizing DCVax-l anticipated BLA filing.
Market Data 
Markets 
